Compound Detail
CHEMBL4776495
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4776495 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | GYOQTAALDYZTEA-UHFFFAOYSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
356.5
MW (Da)
3.12
ALogP
5
HBA
1
HBD
61.6
PSA (Ų)
0.89
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 4.64
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MCF7 | IC50 | = | 22960.0 | nM | 4.64 | Antitumor activity against human MCF7 cells assessed as inhibition of cell viabi... | 33065442 |
| HCT-116 | IC50 | = | 33590.0 | nM | 4.47 | Antitumor activity against human HCT-116 cells assessed as inhibition of cell vi... | 33065442 |
| HepG2 | IC50 | = | 37150.0 | nM | 4.43 | Antitumor activity against human HepG2 cells assessed as inhibition of cell viab... | 33065442 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33065442 | 10.1016/j.bmc.2020.115674 | HCT-116 | 1 |
| 33065442 | 10.1016/j.bmc.2020.115674 | MCF7 | 1 |
| 33065442 | 10.1016/j.bmc.2020.115674 | HepG2 | 1 |
| 33065442 | 10.1016/j.bmc.2020.115674 | No relevant target | 1 |
Data from ChEMBL 36 via Core Engine